tiprankstipranks
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
KLRS
Kalaris Therapeutics
RESEARCH TOOLSreports

Kalaris Therapeutics (KLRS) Stock News & Sentiment

374 Followers
Kalaris Therapeutics Announces CFO Resignation, Finance Leadership Shift
Premium
Company Announcements
Kalaris Therapeutics Announces CFO Resignation, Finance Leadership Shift
23h ago
8K
KLRS
Kalaris Therapeutics: Early TH103 Data in nAMD Support Buy Rating and Favorable Risk/Reward Despite Manufacturing Hurdles
Premium
Ratings
Kalaris Therapeutics: Early TH103 Data in nAMD Support Buy Rating and Favorable Risk/Reward Despite Manufacturing Hurdles
25d ago
KLRS
Kalaris Updates TH103 Strategy and Highlights Cash Runway
Premium
Company Announcements
Kalaris Updates TH103 Strategy and Highlights Cash Runway
1M ago
8K
KLRS
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
Premium
Weekend Updates
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
4M ago
BRO
ANNX
Early Clinical Strength and Durability of TH103 Underpin Buy Rating on Kalaris Therapeutics
Premium
Ratings
Early Clinical Strength and Durability of TH103 Underpin Buy Rating on Kalaris Therapeutics
4M ago
KLRS
Kalaris Therapeutics Announces Oversubscribed $50 Million Financing
Premium
Company Announcements
Kalaris Therapeutics Announces Oversubscribed $50 Million Financing
4M ago
8K
KLRS
Kalaris Therapeutics Announces Positive Phase 1a Trial Data
Premium
Company Announcements
Kalaris Therapeutics Announces Positive Phase 1a Trial Data
4M ago
8K
KLRS
More KLRS News >

KLRS News on the Web

Kalaris Therapeutics Announces CFO Resignation, Finance Leadership Shift
TipRanks News
Neutral
Top Kalaris Therapeutics Executive Quietly Unloads Company Shares
TipRanks News
Neutral
Kalaris Therapeutics: Early TH103 Data in nAMD Support Buy Rating and Favorable Risk/Reward Despite Manufacturing Hurdles
TipRanks News
Bullish
Kalaris Therapeutics reports FY25 EPS ($2.85), consensus ($3.70)
TipRanks News
Bullish
Kalaris Therapeutics sees cash runway into 4Q27
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
Kalaris Updates TH103 Strategy and Highlights Cash Runway
TipRanks News
Neutral
Why Kalaris Therapeutics, Inc.’s (KLRS) Stock Is Up 6.94%
AAII
Neutral

News Score - Last 7 Days

Neutral
KLRS
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KLRS’s Media Buzz Sentiment?
1 articles about KLRS were published this week. In an average week, 1.25 articles are published.
    What is KLRS’s weekly average amount of articles?
    In an average week, 1.25 articles about KLRS are published.
      What is KLRS’s News Sentiment?
      50% of articles about KLRS were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week